Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (121-130 of 293) with videos related to

Pageof 30
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 13, 2006
A rapid and reliable procedure to localize subdural electrodes in presurgical evaluation of patients with drug-resistant focal epilepsyF Sebastiano, G Di Gennaro, V Esposito, et al.
Breast Cancer Research and Treatment|December 17, 2009
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group TrialStacy Moulder, Hailun Li, Molin Wang, et al.
Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.
NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.
Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.
Cancer Treatment Reviews|April 24, 2012
Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumorsJohn M Kirkwood, Ahmad Tarhini, Joseph A Sparano, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
Urinary estrogen metabolites and breast cancer: a case-control studyG C Kabat, C J Chang, J A Sparano, et al.
Cancer|August 10, 2022
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancerRima Patel, Malin Hovstadius, Melanie W Kier, et al.
Breast (Edinburgh, Scotland)|August 13, 2021
Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital SystemAllen Mo, Julie Chung, Jeremy Eichler, et al.
Pageof 30

Showing results (121-130 of 293) with videos related to

Sort By:
Pageof 30
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 13, 2006
A rapid and reliable procedure to localize subdural electrodes in presurgical evaluation of patients with drug-resistant focal epilepsyF Sebastiano, G Di Gennaro, V Esposito, et al.
Breast Cancer Research and Treatment|December 17, 2009
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group TrialStacy Moulder, Hailun Li, Molin Wang, et al.
Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.
NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.
Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.
Cancer Treatment Reviews|April 24, 2012
Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumorsJohn M Kirkwood, Ahmad Tarhini, Joseph A Sparano, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
Urinary estrogen metabolites and breast cancer: a case-control studyG C Kabat, C J Chang, J A Sparano, et al.
Cancer|August 10, 2022
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancerRima Patel, Malin Hovstadius, Melanie W Kier, et al.
Breast (Edinburgh, Scotland)|August 13, 2021
Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital SystemAllen Mo, Julie Chung, Jeremy Eichler, et al.
Pageof 30